Alexandros S Ardavanis

Summary

Publications

  1. ncbi request reprint Biweekly gemcitabine (GEM) in combination with erlotinib (ERL): an active and convenient regimen for advanced pancreatic cancer
    Alexandros Ardavanis
    First Department of Medical Oncology, St Savvas Anticancer Hospital, Athens, Greece
    Anticancer Res 29:5211-7. 2009
  2. ncbi request reprint Non-allergic nature of docetaxel-induced acute hypersensitivity reactions
    A Ardavanis
    First Department of Medical Oncology and Laboratory of Nuclear Medicine, St Savas Anticancer Hospital, Athens, Greece
    Anticancer Drugs 15:581-5. 2004
  3. ncbi request reprint Bevacizumab added to the irinotecan and capecitabine combination for advanced colorectal cancer: a well-tolerated, active and convenient regimen
    Alexandros Ardavanis
    First Department of Medical Oncology, St Savvas Anticancer Hospital, Athens, Greece
    Anticancer Res 28:3087-92. 2008
  4. ncbi request reprint Erlotinib monotherapy in patients with advanced non-small cell lung cancer: an effective approach with low toxicity
    Alexandros Ardavanis
    First Department of Medical Oncology, St Savvas Anticancer Hospital, Athens, Greece
    Anticancer Res 28:2409-15. 2008
  5. doi request reprint Trastuzumab plus paclitaxel or docetaxel in HER-2-negative/HER-2 ECD-positive anthracycline- and taxane-refractory advanced breast cancer
    Alexandros Ardavanis
    First Department of Medical Oncology, Saint Savas Oncology Hospital, 171 Alexandras Avenue, 115 22 Athens, Hellas
    Oncologist 13:361-9. 2008
  6. ncbi request reprint Low-dose capecitabine in breast cancer patients with symptomatic bone marrow infiltration: a case study
    A Ardavanis
    First Department of Medical Oncology, Aghios Savvas Anticancer Hospital, Athens, Greece
    Anticancer Res 28:539-41. 2008
  7. ncbi request reprint Gemcitabine and oral vinorelbine as salvage treatment in patients with advanced anthracycline- and taxane-pretreated breast cancer
    A Ardavanis
    First Department of Medical Oncology, Ag Savvas Anticancer Hospital, Athens, Greece
    Anticancer Res 27:2989-92. 2007
  8. ncbi request reprint Paraneoplastic cerebellar degeneration in a patient with pseudomyxoma peritonei and breast cancer: case report and literature review
    Alexandros Ardavanis
    First Department of Medical Oncology, Athens, Greece
    In Vivo 23:835-8. 2009
  9. ncbi request reprint Skin metastases from primary lung cancer. Report of three cases and a brief review
    Alexandros Ardavanis
    First Department of Medical Oncology, St Savvas Anticancer Hospital, Athens, Greece
    In Vivo 20:671-3. 2006
  10. ncbi request reprint Multidisciplinary therapy of locally far-advanced or inflammatory breast cancer with fixed perioperative sequence of epirubicin, vinorelbine, and Fluorouracil chemotherapy, surgery, and radiotherapy: long-term results
    Alexandros Ardavanis
    First Department of Medical Oncology, St Savas Anticancer Hospital, 171 Alexandras Avenue, 115 22 Athens, Greece
    Oncologist 11:563-73. 2006

Collaborators

Detail Information

Publications23

  1. ncbi request reprint Biweekly gemcitabine (GEM) in combination with erlotinib (ERL): an active and convenient regimen for advanced pancreatic cancer
    Alexandros Ardavanis
    First Department of Medical Oncology, St Savvas Anticancer Hospital, Athens, Greece
    Anticancer Res 29:5211-7. 2009
    ..The secondary aim was to record treatment related toxicities...
  2. ncbi request reprint Non-allergic nature of docetaxel-induced acute hypersensitivity reactions
    A Ardavanis
    First Department of Medical Oncology and Laboratory of Nuclear Medicine, St Savas Anticancer Hospital, Athens, Greece
    Anticancer Drugs 15:581-5. 2004
    ..If the former is demonstrated by further study, the safety of DT administration will be confirmed, and the pre- and post-medication practice might be revisited...
  3. ncbi request reprint Bevacizumab added to the irinotecan and capecitabine combination for advanced colorectal cancer: a well-tolerated, active and convenient regimen
    Alexandros Ardavanis
    First Department of Medical Oncology, St Savvas Anticancer Hospital, Athens, Greece
    Anticancer Res 28:3087-92. 2008
    ..The safety and efficacy of the addition of BEV to the IRI and CAP (XELIRI) regimen were retrospectively analyzed and reported...
  4. ncbi request reprint Erlotinib monotherapy in patients with advanced non-small cell lung cancer: an effective approach with low toxicity
    Alexandros Ardavanis
    First Department of Medical Oncology, St Savvas Anticancer Hospital, Athens, Greece
    Anticancer Res 28:2409-15. 2008
    ..This retrospective study was conducted to assess the efficacy of erlotinib and its impact on survival...
  5. doi request reprint Trastuzumab plus paclitaxel or docetaxel in HER-2-negative/HER-2 ECD-positive anthracycline- and taxane-refractory advanced breast cancer
    Alexandros Ardavanis
    First Department of Medical Oncology, Saint Savas Oncology Hospital, 171 Alexandras Avenue, 115 22 Athens, Hellas
    Oncologist 13:361-9. 2008
    ....
  6. ncbi request reprint Low-dose capecitabine in breast cancer patients with symptomatic bone marrow infiltration: a case study
    A Ardavanis
    First Department of Medical Oncology, Aghios Savvas Anticancer Hospital, Athens, Greece
    Anticancer Res 28:539-41. 2008
    ..The aim of treatment to these patients is palliation. In this study, we sought to determine the efficacy of therapy with low doses of capecitabine in this subgroup of patients...
  7. ncbi request reprint Gemcitabine and oral vinorelbine as salvage treatment in patients with advanced anthracycline- and taxane-pretreated breast cancer
    A Ardavanis
    First Department of Medical Oncology, Ag Savvas Anticancer Hospital, Athens, Greece
    Anticancer Res 27:2989-92. 2007
    ..We sought to determine the efficacy of gemcitabine (GC) and oral vinorelbine (VB) in heavily preatreated ABC...
  8. ncbi request reprint Paraneoplastic cerebellar degeneration in a patient with pseudomyxoma peritonei and breast cancer: case report and literature review
    Alexandros Ardavanis
    First Department of Medical Oncology, Athens, Greece
    In Vivo 23:835-8. 2009
    ..Early recognition and appropriate therapy of this rare complication of PMP is imperative as it may be crucial for the outcome...
  9. ncbi request reprint Skin metastases from primary lung cancer. Report of three cases and a brief review
    Alexandros Ardavanis
    First Department of Medical Oncology, St Savvas Anticancer Hospital, Athens, Greece
    In Vivo 20:671-3. 2006
    ..The eventual association of skin metastases and a phenotype with "CNS-predilection" or an aggressive phase of NSCLC are discussed...
  10. ncbi request reprint Multidisciplinary therapy of locally far-advanced or inflammatory breast cancer with fixed perioperative sequence of epirubicin, vinorelbine, and Fluorouracil chemotherapy, surgery, and radiotherapy: long-term results
    Alexandros Ardavanis
    First Department of Medical Oncology, St Savas Anticancer Hospital, 171 Alexandras Avenue, 115 22 Athens, Greece
    Oncologist 11:563-73. 2006
    ..Based on phase II data in advanced breast cancer (BC), the fluorouracil, epirubicin, and vinorelbine (FEN) combination was assessed as perioperative chemotherapy, integrated in a multidisciplinary treatment for locally advanced BC...
  11. ncbi request reprint Salvage treatment with single-agent capecitabine in patients with heavily pretreated advanced colorectal cancer
    Alexandros S Ardavanis
    St Savas Anticancer Oncologic Hospital, First Department of Medical Oncology, Athens, Greece
    Anticancer Res 26:1669-72. 2006
    ....
  12. ncbi request reprint First-line chemotherapy with fluorouracil-epirubicin-navelbine (FEN) combination in advanced breast cancer
    A Ardavanis
    First Department of Medical Oncology, St Savas Anticancer Hospital, Athens, Greece
    Anticancer Res 25:4493-8. 2005
    ..A phase II study was carried out to determine the safety and efficacy of the combination of vinorelbine, epirubicin and 5-fluorouracil (FEN) as first-line chemotherapy in advanced breast cancer (BC)...
  13. ncbi request reprint Safety and efficacy of trastuzumab every 3 weeks combined with cytotoxic chemotherapy in patients with HER2-positive recurrent breast cancer: findings from a case series
    Alexandros Ardavanis
    First Department of Medical Oncology, St Savas Anticancer Hospital, Athens, Greece
    Onkologie 28:558-64. 2005
    ..Trastuzumab is currently licensed as a weekly treatment, although a 3-weekly schedule could be used conveniently in combination with other cytotoxic agents that are administered on a 3-weekly basis in metastatic breast cancer...
  14. ncbi request reprint Acute myopathy in a patient with lung adenocarcinoma treated with gemcitabine and docetaxel
    Alexandros S Ardavanis
    First Department of Medical Oncology, St Savas Anticancer Oncologic Hospital, Athens, Greece
    Anticancer Res 25:523-5. 2005
    ..The syndrome regressed definitely after the discontinuation of chemotherapy and the administration of corticosteroids. The diagnosis of drug-induced myositis is supported after the exclusion of other possible diagnoses...
  15. pmc Gemcitabine and docetaxel as first-line treatment for advanced urothelial carcinoma: a phase II study
    A Ardavanis
    1st Department of Medical Oncology, St Savas Anticancer Hospital, 171 Alexandras Avenue, 11522 Athens, Greece
    Br J Cancer 92:645-50. 2005
    ....
  16. ncbi request reprint Bevacizumab combined with two-weekly paclitaxel as first-line therapy for metastatic breast cancer
    Panteleimon Kountourakis
    First Department of Medical Oncology, St Savas Anticancer Hospital, 171 Alexandras Avenue, 11522 Athens, Greece
    Anticancer Res 30:2969-71. 2010
    ..Herein, this study sought to investigate an alternative bevacizumab-taxane regimen as first-line treatment for metastatic breast cancer...
  17. ncbi request reprint Clinical significance of kallikrein-related peptidase 7 (KLK7) in colorectal cancer
    Maroulio Talieri
    Department of Cellular Physiology, G Papanicolaou Research Center of Oncology, Saint Savas Hospital, Athens, Greece
    Thromb Haemost 101:741-7. 2009
    ..Present data suggest that KLK7 gene is up-regulated in colon cancer and its expression predicts poor prognosis for colon cancer patients...
  18. ncbi request reprint CD4+CD25+ regulatory T-cell frequency in HER-2/neu (HER)-positive and HER-negative advanced-stage breast cancer patients
    Sonia A Perez
    Cancer Immunology and Immunotherapy Center, Saint Savas Cancer Hospital, Athens, Greece
    Clin Cancer Res 13:2714-21. 2007
    ..Circulating Tregs in correlation with HER-2/neu (HER) status and treatment with chemotherapy, either alone or in combination with trastuzumab therapy, were monitored in advanced-stage breast cancer patients...
  19. pmc Salvage therapy of pretreated advanced breast cancer with bevacizumab and paclitaxel every two weeks: a retrospective case review study
    Alexandros Ardavanis
    Department of Medical Oncology, St Savas Anticancer Hospital, Athens, Greece
    BMC Cancer 9:338. 2009
    ..The activity of this combination in pretreated patients is not known...
  20. ncbi request reprint Comparison of HER2 detection methods between central and regional laboratories in Greece
    Savvas Papadopoulos
    Department of Pathology, Hygeia Hospital Harvard Medical International, Maroussi, Athens, Greece
    Clin Breast Cancer 7:784-90. 2007
    ..This study compares immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) HER2 testing at central and regional laboratories in Greece...
  21. doi request reprint A phase I trial of adoptive transfer of allogeneic natural killer cells in patients with advanced non-small cell lung cancer
    Eleni G Iliopoulou
    Cancer Immunology and Immunotherapy Center, Saint Savas Cancer Hospital, 171 Alexandras Avenue, 115 22, Athens, Greece
    Cancer Immunol Immunother 59:1781-9. 2010
    ..In conclusion, repetitive infusions of allogeneic, in vitro activated and expanded with IL-15/HC NK cells, in combination with chemotherapy are safe and potentially clinically effective...
  22. ncbi request reprint Systemic sclerosis associated with rectal cancer. Case report and a brief review of the literature
    George Orphanos
    First Department of Medical Oncology, Ag Savvas Anticancer Hospital, Athens, Greece
    In Vivo 22:825-9. 2008
    ....
  23. ncbi request reprint Increased frequency of CD4+ cells expressing CD161 in cancer patients
    Eleni G Iliopoulou
    Cancer Immunology and Immunotherapy Center, Saint Savas Cancer Hospital, Athens, Greece
    Clin Cancer Res 12:6901-9. 2006
    ..In the present study, we examined T cells expressing CD161 in the peripheral blood, the tumor tissue and in malignant effusions of patients with several types of malignancies...